Screener
Mirum Pharmaceuticals, Inc. MIRM Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s operating lease liability - undiscounted excess amount?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liability - undiscounted excess amount of $2.49M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating lease liability - undiscounted excess amount changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating lease liability - undiscounted excess amount increased by 52.4% year-over-year, from $1.63M to $2.49M.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude